Recognition of Human Diversity and Respect and Tolerance for People with Disabilities

The committee heard powerful and moving testimony from individuals with disabilities who believe that genetic testing and the consequent increase in abortion promote the premise that individuals with disabilities (whether tests exist for early detection or not) have less intrinsic worth. They pointed out that many people with disabilities lead full and productive lives and that society's negative view of disabilities is sometimes of greater harm to them than the disabilities themselves (Waxman, 1992). Some people with disabilities would resist any expansion of genetic testing. The committee recognizes the weight of these concerns and urges broad public education to dispel myths about people with disabilities—genetic or otherwise—and to reduce barriers to their participation in society (see Chapter 5). The committee rejects the notion of restricting any expansion of genetic testing based on the concerns of persons with disabilities that the technologies are inherently harmful. Such a restriction would undermine individual autonomy as much as the view that people should be urged or forced to use genetic tests and abortion to prevent disabilities. Nevertheless, the concerns of persons with disabilities are critical ones for our society. The committee is concerned that society may be moving closer to adopting the view that people should be urged or forced to use genetic tests and abortion to prevent disabilities; steps must be taken to counteract this tendency by decreasing pressures to test and increasing education and understanding of disabilities. If testing becomes widespread, efforts to urge people to undergo genetic testing might engender a greater intolerance for persons with disabilities—even though most disabilities are not the result of genetic causes. Avoiding the social pitfalls of intolerance based on genetic testing will require continuing vigilance.

REFERENCES

American College of Obstetrics and Gynecology (ACOG). 1988. Ultrasound in Pregnancy (Technical Bulletin No. 116), Washington, D.C.

American Medical Association (AMA). 1992. Resolution of the AMA House of Delegates on Physician Ownership and Self-Referral. December 12, 1992.

Andrews, L. 1992. Torts and the double helix: Malpractice liability for failure to warn of genetic risks. 29 Houston Law Review 149.

Angastiniotis, M. 1990. Cyprus: Thalassemia programme. Lancet 336:119-120.


Baron, M., et al. 1992. Diminished support for linkage between manic depressive illness and X-chromosome markers in three Israeli pedigrees. Nature Genetics 3:49-55.

Bianchi, D., et al. 1991. Fetal cells in maternal blood: Prospects for non-invasive prenatal diagnosis. Paper presented at the International Congress of Human Genetics, Washington, D.C.

Botstein, D., et al. 1980. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. American Journal of Human Genetics 32:314-331.


Cao, A., et al. 1981. Prevention of homozygous beta-thalassemia by carrier screening and prenatal diagnosis in Sardinia. American Journal of Human Genetics 33:592-605.

Cao, A., et al. 1989. The prevention of thalassemia in Sardinia. Clinical Genetics 36:277-285.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement